New guidelines
U.S. guidelines for primary care and the general specialties published in the last 90 days, newest first. The list is checked every morning.
-
2027 GOLD Report
-
American Cancer Society guideline for the early detection of prostate cancer, 2026
The ACS recommends PSA screening at intervals and ages based on men’s risk, with informed discussion before screening and further evaluation of elevated PSA levels. Screening is not recommended for men with a life expectancy <10 years and should be discontinued at age 75 years.
-
Early ambulatory re-evaluation and follow-up of patients admitted in the acute cardiac care unit -…
The Association for Acute CardioVascular Care of the ESC provides condition-specific guidance on structured post-discharge management and early ambulatory re-evaluation for patients admitted to an acute cardiac care unit. It covers follow-up timing, content, organization, and multidisciplinary and hybrid care.
-
AAFP endorses updated migraine prevention guideline
The AAFP-endorsed guideline recommends offering preventive medication to adults with four or more migraine days per month, four or more moderate-to-severe headache days per month, or substantial migraine-related disability. It advises considering medical history, potential side effects, cost, and patient preferences when choosing a medication.
-
As-needed inhaled corticosteroids in asthma: an Official American Thoracic Society clinical practice guideline
The American Thoracic Society recommends inhaled corticosteroid-containing reliever therapy for adolescents and adults with asthma, with specific options based on NAEPP treatment steps. These include as-needed ICS-SABA or ICS-formoterol at steps 1 and 2 and maintenance-and-reliever therapy with ICS-formoterol at steps 3-5.
-
AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis
The AGA and AASLD guideline recommends approaches to diagnose and manage primary biliary cholangitis in adults, including first-line ursodeoxycholic acid, treatment escalation for inadequate response or intolerance, pruritus treatment, and prevention of recurrence after transplantation.
-
Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for…
The American Academy of Dermatology and Hidradenitis Suppurativa Foundation recommend evidence-based management of hidradenitis suppurativa, including strong recommendations for several medications and routine pain assessment. Conditional recommendations cover additional medications, procedural interventions, tobacco cessation, pain management, and supplementation.
-
Clinical Practice Guideline: Tinnitus Update
AAO-HNSF recommends evaluation and evidence-based management for adults with persistent, bothersome tinnitus, including education and Cognitive Behavioral Therapy. It advises against routine imaging without concerning features and against several medications, supplements, and repetitive transcranial magnetic stimulation for tinnitus.
-
Executive Summary of the Clinical Practice Guideline on Tinnitus Update
AAO-HNSF recommends evaluating adults with persistent, bothersome tinnitus and assessing its effects, including risks for self-harm. Recommendations include education, Cognitive Behavioral Therapy, and hearing aid or cochlear implant evaluation when appropriate.
-
VA/DoD Clinical Practice Guideline: Management of Chronic Obstructive Pulmonary Disease (COPD) (2026)
-
Pharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From…
For females seeking treatment of menopausal vasomotor symptoms, ACP recommends estrogen with progestogen for those with a uterus or estrogen alone for those without one. It suggests alternative medications when first-line treatment is contraindicated or not tolerated, with treatment choices guided by informed discussion of benefits, harms, and patient preferences.
-
Optimizing Blood Pressure Care in Patients With Resistant Hypertension: 2026 ACC Expert Consensus…
-
VA/DoD Clinical Practice Guideline: Menopause (2026)
-
AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular…
The AGA advises individualized decisions about pancreatic cyst and hepatocellular carcinoma surveillance in older adults, considering comorbidities, life expectancy, risks, and treatment candidacy. It recommends considering when to stop surveillance through shared decision-making.
-
EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy
The joint EASL-EASD-EASO guidance recommends resmetirom or semaglutide for adults with non-cirrhotic MASH and fibrosis stages 2-3, alongside lifestyle intervention and optimized comorbidity management. It addresses treatment selection, initiation, monitoring, and discontinuation, and advises against using these agents as MASH-targeted therapy in adults with MASH cirrhosis until further data are available.
-
Clinical Practice Guideline for the Diagnosis and Treatment of Urinary Tract Infection in Children…
The AAP guideline provides recommendations for diagnosing and managing urinary tract infections in children 8 days to 5 years of age with low medical complexity. It covers medical evaluation, antibiotic treatment, imaging, prevention strategies, and evaluation and treatment of bowel and bladder dysfunction.
-
2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management…
The ACC/AHA guideline recommends approaches to perioperative cardiovascular evaluation and management for adults undergoing noncardiac surgery, including evidence-based strategies for cardiovascular disease and associated conditions.
-
Tobacco Use Treatment: Synopsis of the 2026 U.S. Department of Veterans Affairs and U.S. Department…
The 2026 VA/DoD guideline recommends motivational interviewing and FDA-approved pharmacotherapies to increase abstinence from combustible tobacco, with varenicline preferred over other single-agent medications and combination NRT preferred over NRT alone. It also addresses treatment for smokeless tobacco, electronic nicotine delivery systems, and patients not ready to quit within 30 days.
-
AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction- and…
The AGA recommends assessing alcohol use in all patients with steatotic liver disease, advising alcohol cessation, and using tiered noninvasive testing to assess fibrosis risk. For patients with MetALD, it also recommends lifestyle and cardiometabolic risk management and alcohol use disorder treatment when indicated.
-
2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress…
EASD recommends routine, person-centred assessment and monitoring of diabetes distress among adults with type 1 or type 2 diabetes. It conditionally recommends specific psychological, technology-based, psychoeducational and educational interventions to reduce distress, depending on diabetes type.
-
VA/DoD Clinical Practice Guideline: Hypertension (HTN) (2026)
-
American Society of Hematology 2026 guidelines for diagnosis of iron deficiency
The American Society of Hematology recommends serum ferritin thresholds for diagnosing iron deficiency in specific populations, whether or not anemia is present, and provides guidance for people with inflammation. The guidelines also discuss other diagnostic thresholds and research priorities.
These summaries are for general reference only. They are not official guidance and not medical advice. Guidelines are updated often, so check the issuing organization’s own website for the current version before relying on any recommendation.